COMPANY PROFILE

On Target Laboratories

Explore full profile

Make cancer visible during surgery so it can be removed more completely

Northbrook, United StatesFounded 2010Biotech & Life Sciences

Valuation $100–250M Last recorded · 2023

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About On Target Laboratories

On Target Laboratories specializes in the discovery and development of fluorescent markers that target and illuminate cancerous tissues during surgical procedures. This technology provides surgeons with enhanced intraoperative visibility, potentially increasing the likelihood of complete cancer resection. The primary clients are healthcare providers, particularly surgeons and hospitals, operating in the oncology sector. On Target Laboratories operates within the medical technology market, focusing on innovative solutions to improve surgical outcomes. The business model revolves around the research, development, and commercialization of its fluorescent imaging technology. Revenue is generated through the sale of these specialized markers and potentially through partnerships or licensing agreements with medical institutions and technology firms.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2010
Headquarters: Northbrook, United States
Employees: 80
Open positions: None listed
Dealroom signal: 93.5/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Nov 2023	$30M	$200M	Johnson & Johnson Innovation · HIG Capital · 3B Future Health Fund · Elevate Ventures	↗
CONVERTIBLEOther financing	Dec 2022	$3M	—	Elevate Ventures	—

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

On Target Laboratories website traffic

Latest recorded traffic for On Target Laboratories is 1.4K monthly website visits, up 16.7% over the last three months. On Target Laboratories's team grew 33.3% over the past year.

Latest monthly visits1.4K 3-month web change+16.7% 1-year team growth+33.3%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SBSuzhou Linaxin BiotechnologySpecializing in solid-state nanopore gene detectors	China	Operational	—	$2.8M	$11M
ZBZhuhai Medefa BiotechnologyInnovative biodegradable PHA materials for medical devices and eco-friendly applications	China	Operational
STSmart TissuesRegenerative therapies for chronic wound tissue repair.	Kyoto, Japan	Operational
LBLo BioLo Bio is bridging patients to labs with better blood collection tools	North Bethesda, United States	Operational
RBRealmind BiotechFocuses on the R&D, production and sales of POCT real-time detection innovation platforms and specialty reagent projects	Nanjing City, China	Operational
ALABLE LabsAims to contribute to improving human health by providing bio-automated solutions	Incheon, South Korea	Operational
KMKunmai MedicalMedical equipment company with biological weak magnetic detection as its core technology	China	Operational
VEVeinTechA medical device company aiming to improve patient and physician experience in vascular access practices	West Leederville, Australia	Operational